D. Bression

发表

Steroid receptor content in cytosol from normal and hyperplastic human prostates.

J. Gustafsson, P. Ekman, B. Högberg, 1979, The Journal of clinical endocrinology and metabolism.

Evidence of receptors for thyrotropin-releasing hormone in human prolactin-secreting adenomas.

F. Peillon, A. Brandi, M. Le Dafniet, 1983, The Journal of clinical endocrinology and metabolism.

Characterization and Measurement of the Androgen Receptor in Human Benign Prostatic Hyperplasia and Prostatic Carcinoma

J. Gustafsson, P. Ekman, B. Högberg, 1977 .

Cyclic uptake of steroids in cells and cell nuclei from prostate, liver and pituitary

J. Gustafsson, P. Ekman, A. Bélanger, 1979, FEBS letters.

Epidermal growth factor-binding sites, present in normal human and rat pituitaries, are absent in human pituitary adenomas.

F. Peillon, J. Y. Li, P. Birman, 1987, The Journal of clinical endocrinology and metabolism.

Estrogen receptors in human pituitary adenomas.

E. Milgrom, F. Peillon, M. Pichon, 1980, The Journal of clinical endocrinology and metabolism.

Alterations in central neurotransmitter receptor binding sites following estradiol implantation in female rats

M. Hamon, F. Peillon, A. Brandi, 1983, Neurochemistry International.

Evidence of dopamine receptors in human growth hormone (GH)-secreting adenomas with concomitant study of dopamine inhibition of GH secretion in a perifusion system.

F. Peillon, A. Brandi, J. Racadot, 1982, The Journal of clinical endocrinology and metabolism.

Dopaminergic receptors in human prolactin-secreting adenomas: a quantitative study.

M. Martres, F. Peillon, A. Brandi, 1980, The Journal of clinical endocrinology and metabolism.

Partial characterization of [3H]methyltrienolone binding in rat prostate cytosol.

J. Gustafsson, B. Högberg, Å. Pousette, 1979, Biochimica et biophysica acta.

In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.

F. Peillon, A. Mauborgne, A. Brandi, 1979, The Journal of clinical endocrinology and metabolism.

Evidence for a specific estradiol binding site on rat pituitary membranes.

P. Pagésy, F. Peillon, M. Le Dafniet, 1986, Endocrinology.

Paradoxical response of thyrotropin to L-dopa and presence of dopaminergic receptors in a thyrotropin-secreting pituitary adenoma.

P. Chanson, F. Peillon, J. Orgiazzi, 1984, The Journal of clinical endocrinology and metabolism.

Evidence of thyrotropin-releasing hormone (TRH) and TRH-binding sites in human nonsecreting pituitary adenomas.

F. Peillon, D. Grouselle, M. Kujas, 1987, The Journal of clinical endocrinology and metabolism.

Correlative studies between the presence of thyrotropin-releasing hormone (TRH) receptors and the in vitro stimulation of growth-hormone (GH) secretion in human GH-secreting adenomas.

F. Peillon, A. Brandi, J. Racadot, 1985, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

In vitro and in vivo antagonistic regulation by estradiol and progesterone of the rat pituitary domperidone binding sites: correlation with ovarian steroid regulation of the dopaminergic inhibition of prolactin secretion in vitro.

P. Pagésy, F. Peillon, A. Brandi, 1985, Endocrinology.

[Release of thyrotropin releasing hormone (TRH) from human prolactin-secreting pituitary adenoma cells. Modulation by dopamine].

F. Peillon, A. Brandi, M. Feinstein, 1988, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

Binding of (+)-PN 200-110 to rat pituitaries and to normal and adenomatous human pituitaries

P. Chaumet‐Riffaud, F. Peillon, A. Brandi, 1987, Molecular and Cellular Endocrinology.

Modifications of the high and low affinity pituitary domperidone-binding sites in chronic estrogenized rats.

M. Hamon, F. Peillon, B. Kerdelhué, 1983, Endocrinology.